Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
Saved in:
| Title: | Sacubitril/valsartan for the treatment of non‐obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM). |
|---|---|
| Authors: | Velicki, Lazar1,2 (AUTHOR), Popovic, Dejana3 (AUTHOR), Okwose, Nduka C.4,5 (AUTHOR), Preveden, Andrej1,2 (AUTHOR), Tesic, Milorad3 (AUTHOR), Tafelmeier, Maria6 (AUTHOR), Charman, Sarah J.4 (AUTHOR), Barlocco, Fausto7 (AUTHOR), MacGowan, Guy A.4,8 (AUTHOR), Seferovic, Petar M.3 (AUTHOR), Filipovic, Nenad9,10 (AUTHOR), Ristic, Arsen3 (AUTHOR), Olivotto, Iacopo7 (AUTHOR), Maier, Lars S.6 (AUTHOR), Jakovljevic, Djordje G.4,5,8 (AUTHOR) djordje.jakovljevic@coventry.ac.uk, Redzek, Aleksandar (AUTHOR), Bjelobrk, Marija (AUTHOR), Ilic, Aleksandra (AUTHOR), Golubovic, Miodrag (AUTHOR), Miljkovic, Tatjana (AUTHOR) |
| Source: | European Journal of Heart Failure. Jun2024, Vol. 26 Issue 6, p1361-1368. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
